2017 Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Schetelig J Journal Bone Marrow Transplant.
2017 Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Scheid C Journal Bone Marrow Transplant.
2017 Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. Group Chronic Malignancies Working Party (CMWP) 1st listed author de Witte T Journal Blood
2016 Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Heidenreich S Journal Biol Blood Marrow Transplant.
2016 Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research. Group Chronic Malignancies Working Party (CMWP) 1st listed author Potter VT Journal Biol Blood Marrow Transplant.
2016 Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Koenecke C Journal Bone Marrow Transplant.
2016 Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Paviglianiti A Journal Haematologica.
2016 Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Cremers EM Journal Ann Hematol.
2016 Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gratwohl A Journal Ann Hematol.
2016 Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). Group Chronic Malignancies Working Party (CMWP) 1st listed author Bruno B Journal Leuk Lymphoma.
2016 Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting. Group Chronic Malignancies Working Party (CMWP) 1st listed author Garderet L Journal Leuk Lymphoma.
2016 Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Robin M Journal Bone Marrow Transplant.